U.S. pharma giant copyright scrapped two experimental weight loss tablets final yr—a at the time-daily pill, lotiglipron, because of elevated liver enzymes and also a 2 times-day by day capsule, danuglipron, as a result of strong Unintended effects—but CEO Albert Bourla has reported the company is determined to “Participate in and get” from… Read More